US Patent Issued to Principia Biopharma on April 22 for "Processes for preparing an FGFR inhibitor" (California Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,110, issued on April 22, was assigned to Principia Biopharma Inc. (Bridgewater, N.J.).

"Processes for preparing an FGFR inhibitor" was invented by Jiang Zhu (San Ramon, Calif.) and Mohammad Masjedizadeh (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are processes for preparing 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one and FGFR inhibitor, as well as polymorphs and/or salt forms thereof."

The patent was filed on Jan. 22, 2021, under Application No. 17/155,726.

*For further information, including images, charts and tables, please visit:...